{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:19:26Z","timestamp":1791422366768,"version":"4.3.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,6,2]],"date-time":"2015-06-02T00:00:00Z","timestamp":1433203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,6,2]],"date-time":"2015-06-02T00:00:00Z","timestamp":1433203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic hepatitis B virus (HBV) infection is prevalent, deadly and seldom cured due to the persistence of viral episomal DNA (cccDNA) in infected cells. Newly developed genome engineering tools may offer the ability to directly cleave viral DNA, thereby promoting viral clearance. Here, we show that the CRISPR\/Cas9 system can specifically target and cleave conserved regions in the HBV genome, resulting in robust suppression of viral gene expression and replication. Upon sustained expression of Cas9 and appropriately chosen guide RNAs, we demonstrate cleavage of cccDNA by Cas9 and a dramatic reduction in both cccDNA and other parameters of viral gene expression and replication. Thus, we show that directly targeting viral episomal DNA is a novel therapeutic approach to control the virus and possibly cure patients.<\/jats:p>","DOI":"10.1038\/srep10833","type":"journal-article","created":{"date-parts":[[2015,6,2]],"date-time":"2015-06-02T13:54:13Z","timestamp":1433253253000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":279,"title":["CRISPR\/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus"],"prefix":"10.1038","volume":"5","author":[{"given":"Vyas","family":"Ramanan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Shlomai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.T.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Michailidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Bhatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta N.","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,2]]},"reference":[{"key":"BFsrep10833_CR1","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1056\/NEJMra0801644","volume":"359","author":"JL Dienstag","year":"2008","unstructured":"Dienstag, J. L. Hepatitis B Virus Infection. New England Journal of Medicine 359, 1486\u20131500, doi:10.1056\/NEJMra0801644 (2008).","journal-title":"New England Journal of Medicine"},{"key":"BFsrep10833_CR2","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1146\/annurev.bi.56.070187.003251","volume":"56","author":"D Ganem","year":"1987","unstructured":"Ganem, D. & Varmus, H. E. The molecular biology of the hepatitis B viruses. Annu Rev Biochem 56, 651\u2013693 (1987).","journal-title":"Annu Rev Biochem"},{"key":"BFsrep10833_CR3","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1126\/science.1252186","volume":"343","author":"A Shlomai","year":"2014","unstructured":"Shlomai, A. & Rice, C. M. Getting Rid of a Persistent Troublemaker to Cure Hepatitis. Science 343, 1212\u20131213, doi:10.1126\/science.1252186 (2014).","journal-title":"Science"},{"key":"BFsrep10833_CR4","doi-asserted-by":"crossref","unstructured":"Lucifora, J. et al. Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA. Science, doi:10.1126\/science.1243462 (2014).","DOI":"10.1126\/science.1243462"},{"key":"BFsrep10833_CR5","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1038\/mt.2013.170","volume":"21","author":"K Bloom","year":"2013","unstructured":"Bloom, K., Ely, A., Mussolino, C., Cathomen, T. & Arbuthnot, P. Inactivation of Hepatitis B Virus Replication in Cultured Cells and In Vivo with Engineered Transcription Activator-Like Effector Nucleases. Mol Ther 21, 1889\u20131897, doi:10.1038\/mt.2013.170 (2013).","journal-title":"Mol Ther"},{"key":"BFsrep10833_CR6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/mt.2013.212","volume":"22","author":"J Chen","year":"2014","unstructured":"Chen, J. et al. An Efficient Antiviral Strategy for Targeting Hepatitis B Virus Genome Using Transcription Activator-Like Effector Nucleases. Mol Ther 22, 303\u2013311, doi:10.1038\/mt.2013.212 (2014).","journal-title":"Mol Ther"},{"key":"BFsrep10833_CR7","doi-asserted-by":"publisher","first-page":"e97579","DOI":"10.1371\/journal.pone.0097579","volume":"9","author":"ND Weber","year":"2014","unstructured":"Weber, N. D. et al. AAV-Mediated Delivery of Zinc Finger Nucleases Targeting Hepatitis B Virus Inhibits Active Replication. PLoS ONE 9, e97579, doi:10.1371\/journal.pone.0097579 (2014).","journal-title":"PLoS ONE"},{"key":"BFsrep10833_CR8","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong, L. et al. Multiplex Genome Engineering Using CRISPR\/Cas Systems. Science 339, 819\u2013823, doi:10.1126\/science.1231143 (2013).","journal-title":"Science"},{"key":"BFsrep10833_CR9","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.1232033","volume":"339","author":"P Mali","year":"2013","unstructured":"Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823\u2013826, doi:10.1126\/science.1232033 (2013).","journal-title":"Science"},{"key":"BFsrep10833_CR10","doi-asserted-by":"crossref","unstructured":"Hu, W. et al. RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection. Proceedings of the National Academy of Sciences, doi:10.1073\/pnas.1405186111 (2014).","DOI":"10.1073\/pnas.1405186111"},{"key":"BFsrep10833_CR11","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/S0076-6879(04)92020-4","volume":"392","author":"DL Lewis","year":"2005","unstructured":"Lewis, D. L. & Wolff, J. A. Delivery of siRNA and siRNA expression constructs to adult mammals by hydrodynamic intravascular injection. Methods Enzymol 392, 336\u2013350 (2005).","journal-title":"Methods Enzymol"},{"key":"BFsrep10833_CR12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1247005","volume":"343","author":"O Shalem","year":"2014","unstructured":"Shalem, O. et al. Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells. Science 343, 84\u201387, doi:10.1126\/science.1247005 (2014).","journal-title":"Science"},{"key":"BFsrep10833_CR13","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","volume":"84","author":"MA Sells","year":"1987","unstructured":"Sells, M. A., Chen, M.-L. & Acs, G. Production of Hepatitis B Virus Particles in Hep G2 Cells Transfected with Cloned Hepatitis B Virus DNA. PNAS 84, 1005\u20131009, doi:10.1073\/pnas.84.4.1005 (1987).","journal-title":"PNAS"},{"key":"BFsrep10833_CR14","doi-asserted-by":"crossref","unstructured":"Yan, H. et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 1, doi:10.7554\/eLife.00049 (2012).","DOI":"10.7554\/eLife.00049"},{"key":"BFsrep10833_CR15","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","volume":"152","author":"LS Qi","year":"2013","unstructured":"Qi, L. S. et al. Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression. Cell 152, 1173\u20131183, doi:10.1016\/j.cell.2013.02.022 (2013).","journal-title":"Cell"},{"key":"BFsrep10833_CR16","doi-asserted-by":"publisher","first-page":"7473","DOI":"10.1093\/nar\/gku402","volume":"42","author":"Y Lin","year":"2014","unstructured":"Lin, Y. et al. CRISPR\/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences. Nucleic Acids Research 42, 7473\u20137485, doi:10.1093\/nar\/gku402 (2014).","journal-title":"Nucleic Acids Research"},{"key":"BFsrep10833_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrg2749","volume":"11","author":"LA Marraffini","year":"2010","unstructured":"Marraffini, L. A. & Sontheimer, E. J. CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nat Rev Genet 11, 181\u2013190 (2010).","journal-title":"Nat Rev Genet"},{"key":"BFsrep10833_CR18","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1101\/gad.1.8.773","volume":"1","author":"T Nagaya","year":"1987","unstructured":"Nagaya, T. et al. The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma. Genes Dev 1, 773\u2013782 (1987).","journal-title":"Genes Dev"},{"key":"BFsrep10833_CR19","doi-asserted-by":"publisher","first-page":"e186","DOI":"10.1038\/mtna.2014.38","volume":"3","author":"S-R Lin","year":"2014","unstructured":"Lin, S.-R. et al. The CRISPR\/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo. Mol Ther Nucleic Acids 3, e186, doi:10.1038\/mtna.2014.38 (2014).","journal-title":"Mol Ther Nucleic Acids"},{"key":"BFsrep10833_CR20","doi-asserted-by":"publisher","first-page":"e216","DOI":"10.1038\/mtna.2014.68","volume":"3","author":"C Seeger","year":"2014","unstructured":"Seeger, C. & Sohn, J. A. Targeting Hepatitis B Virus With CRISPR\/Cas9. Molecular Therapy. Nucleic Acids 3, e216, doi:10.1038\/mtna.2014.68 (2014).","journal-title":"Molecular Therapy. Nucleic Acids"},{"key":"BFsrep10833_CR21","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.virol.2014.12.001","volume":"476","author":"EM Kennedy","year":"2015","unstructured":"Kennedy, E. M. et al. Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR\/Cas RNA-guided DNA endonuclease. Virology 476, 196\u2013205, doi:10.1016\/j.virol.2014.12.001 (2015).","journal-title":"Virology"},{"key":"BFsrep10833_CR22","doi-asserted-by":"crossref","unstructured":"Zhen, S. et al. Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)\/CRISPR-associated Cas9 system to disrupt the hepatitis B virus. Gene Ther, doi:10.1038\/gt.2015.2 (2015).","DOI":"10.1038\/gt.2015.2"},{"key":"BFsrep10833_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nm.3793","volume":"21","author":"DBT Cox","year":"2015","unstructured":"Cox, D. B. T., Platt, R. J. & Zhang, F. Therapeutic genome editing: prospects and challenges. Nat Med 21, 121\u2013131, doi:10.1038\/nm.3793 (2015).","journal-title":"Nat Med"},{"key":"BFsrep10833_CR24","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/hep.23519","volume":"51","author":"D Cohen","year":"2010","unstructured":"Cohen, D., Adamovich, Y., Reuven, N. & Shaul, Y. Hepatitis B virus activates deoxynucleotide synthesis in nondividing hepatocytes by targeting the R2 gene. Hepatology 51, 1538\u20131546, doi:10.1002\/hep.23519 (2010).","journal-title":"Hepatology"},{"key":"BFsrep10833_CR25","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1128\/mcb.24.4.1799-1808.2004","volume":"24","author":"G Doitsh","year":"2004","unstructured":"Doitsh, G. & Shaul, Y. Enhancer I Predominance in Hepatitis B Virus Gene Expression. Molecular and Cellular Biology 24, 1799\u20131808, doi:10.1128\/mcb.24.4.1799-1808.2004 (2004).","journal-title":"Molecular and Cellular Biology"},{"key":"BFsrep10833_CR26","doi-asserted-by":"publisher","first-page":"9511","DOI":"10.1128\/jvi.77.17.9511-9521.2003","volume":"77","author":"D Glebe","year":"2003","unstructured":"Glebe, D. et al. Pre-S1 Antigen-Dependent Infection of Tupaia Hepatocyte Cultures with Human Hepatitis B Virus. Journal of Virology 77, 9511\u20139521, doi:10.1128\/jvi.77.17.9511-9521.2003 (2003).","journal-title":"Journal of Virology"},{"key":"BFsrep10833_CR27","unstructured":"Cai, D. et al. in Antiviral Methods and Protocols Vol. 1030 Methods in Molecular Biology (ed Edwin Yunhao Gong ) Ch. 13, 151\u2013161 (Humana Press, 2013)."},{"key":"BFsrep10833_CR28","doi-asserted-by":"publisher","first-page":"9275","DOI":"10.1093\/nar\/gkr606","volume":"39","author":"R Sapranauskas","year":"2011","unstructured":"Sapranauskas, R. et al. The Streptococcus thermophilus CRISPR\/Cas system provides immunity in Escherichia coli. Nucleic Acids Research 39, 9275\u20139282, doi:10.1093\/nar\/gkr606 (2011).","journal-title":"Nucleic Acids Research"},{"key":"BFsrep10833_CR29","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.2647","volume":"31","author":"PD Hsu","year":"2013","unstructured":"Hsu, P. D. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotech 31, 827\u2013832, doi:10.1038\/nbt.2647 (2013).","journal-title":"Nat Biotech"},{"key":"BFsrep10833_CR30","doi-asserted-by":"crossref","unstructured":"Ran, F.A. et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature, the doi is 10.1038\/nature14299 (2015).","DOI":"10.1038\/nature14299"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep10833","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep10833.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep10833.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T23:20:56Z","timestamp":1672960856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep10833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,2]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,9,1]]}},"alternative-id":["BFsrep10833"],"URL":"https:\/\/doi.org\/10.1038\/srep10833","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,2]]},"assertion":[{"value":"23 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"10833"}}